Hasil Pencarian - Andrea Alonci

  • Menampilkan 1 - 3 hasil dari 3
Perbaiki Hasil
  1. 1
    Efficacy of nilotinib in a young patient with high Sokal risk CML Ph+ in treatment failure after high dose imatinib

    Efficacy of nilotinib in a young patient with high Sokal risk CML Ph+ in treatment failure after high dose imatinib oleh Sabina Russo, Giuseppa Penna, Arianna D’Angelo, Alessandro Allegra, Andrea Alonci, Caterina Musolino

    Diterbitkan 2015-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Possible Role of Interleukin-31/33 Axis in Imatinib Mesylate-Associated Skin Toxicity

    Possible Role of Interleukin-31/33 Axis in Imatinib Mesylate-Associated Skin Toxicity oleh Caterina Musolino, Alessandro Allegra, Carmen Mannucci, Sabina Russo, Andrea Alonci, Valerio Maisano, Gioacchino Calapai, Sebastiano Gangemi

    Diterbitkan 2015-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Diagnostic utility of Sudoscan for detecting bortezomib-induced painful neuropathy: a study on 18 patients with multiple myeloma

    Diagnostic utility of Sudoscan for detecting bortezomib-induced painful neuropathy: a study on 18 patients with multiple myeloma oleh Alessandro Allegra, Vincenzo Rizzo, Vanessa Innao, Angela Alibrandi, Anna Mazzeo, Rossana Leanza, Carmen Terranova, Luca Gentile, Paolo Girlanda, Andrea Gaetano Allegra, Andrea Alonci, Caterina Musolino

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: